Urothelial Carcinoma Bladder

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Intervention of Bladder Cancer by CAR-T

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial

Preoperative Physical Activity Before Radical Cystectomy and the Impact on Morbidity

Phase Ib of L-NMMA and Pembrolizumab

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy

A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT

A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer

Bladder EpiCheck European Haematuria Study